Canada · Delayed Price · Currency is CAD Aptose Biosciences Statistics
Total Valuation
TSX:APS has a market cap or net worth of CAD 6.05 million. The enterprise value is 42.08 million.
| Market Cap | 6.05M |
| Enterprise Value | 42.08M |
Important Dates
The last earnings date was Thursday, April 2, 2026.
| Earnings Date | Apr 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:APS has 2.55 million shares outstanding. The number of shares has increased by 250.13% in one year.
| Current Share Class | 2.55M |
| Shares Outstanding | 2.55M |
| Shares Change (YoY) | +250.13% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 7.37% |
| Owned by Institutions (%) | 3.91% |
| Float | 1.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -0.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.20 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.69
| Current Ratio | 0.69 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -29.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -153.45% |
| Return on Invested Capital (ROIC) | -504.80% |
| Return on Capital Employed (ROCE) | -3,501.84% |
| Weighted Average Cost of Capital (WACC) | 2.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.49M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.44% in the last 52 weeks. The beta is 0.26, so TSX:APS's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -14.44% |
| 50-Day Moving Average | 2.25 |
| 200-Day Moving Average | 1.98 |
| Relative Strength Index (RSI) | 60.06 |
| Average Volume (20 Days) | 4,873 |
Short Selling Information
The latest short interest is 6,975, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 6,975 |
| Short Previous Month | 10,084 |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.05% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -33.90M |
| Pretax Income | -34.92M |
| Net Income | -34.92M |
| EBITDA | -33.87M |
| EBIT | -33.90M |
| Earnings Per Share (EPS) | -14.27 |
Balance Sheet
The company has 1.28 million in cash and 37.31 million in debt, with a net cash position of -36.03 million or -14.12 per share.
| Cash & Cash Equivalents | 1.28M |
| Total Debt | 37.31M |
| Net Cash | -36.03M |
| Net Cash Per Share | -14.12 |
| Equity (Book Value) | -37.25M |
| Book Value Per Share | -14.59 |
| Working Capital | -3.92M |
Cash Flow
| Operating Cash Flow | -30.15M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 30,306 |
| Net Borrowing | 25.55M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:APS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -250.13% |
| Shareholder Yield | -250.13% |
| Earnings Yield | -577.26% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 26, 2025. It was a reverse split with a ratio of 0.0333333.
| Last Split Date | Feb 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0333333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |